Choi Sung-wonChoi Sung-won, president and CEO of Kwang Dong Pharmaceutical Co., was promoted to vice chairman. Choi, 45, has served as CEO of Kwang Dong since July 2013 when his father Choi Soo-boo, founder and chairman of the drug manufacturer, died at the age of 77. He plans to transform the company into Korea's leading healthcare provider, with the goal of generating 1 trillion won ($910 million) in sales by 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,480 KRW | -0.15% |
|
-1.67% | -12.79% |
1st Jan change | Capi. | |
---|---|---|
-12.79% | 187M | |
+20.39% | 43.67B | |
+27.93% | 22.79B | |
+21.43% | 15.45B | |
+18.82% | 14.29B | |
+53.37% | 12.83B | |
-0.05% | 6.79B | |
-12.62% | 6.52B | |
-8.87% | 5.73B | |
+15.72% | 5.59B |
- Stock Market
- Equities
- A009290 Stock
- News Kwang Dong Pharmaceutical Co., Ltd.
- Kwang Dong Pharmaceutical Announces Promotion of Choi Sung-Wonchoi Sung-Won to Vice Chairman